Q4 2024 Earnings Call Transcript November 18, 2024 Operator: Welcome to Twist Bioscience’s 2024 Fourth Quarter Financial ...

Stilla Technologies, a global leader in digital PCR (dPCR) solutions, has announced a strategic partnership with Source ...

COVID-19, influenza, and RSV are on the rise for cold and flu season, and experts said kids are feeling it now.

Daré Bioscience ( (DARE) ) has released its Q3 earnings. Here is a breakdown of the information Daré Bioscience presented to its investors.

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth quarter. On a per-share basis, the ...

Twist Bioscience focuses on synthetic DNA manufacturing, leveraging its proprietary silicon-based platform. Find out why I'm ...

Researchers at Ayass Bioscience have discovered and developed AYA22A aptamers, molecular compounds that target and bind to ...

Daré Bioscience, Inc. ( NASDAQ: DARE) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET MarDee Haring-Layton - CAO Sabrina Martucci Johnson - President and CEO ...

Bioscience and environmental science PhD students at UCL are to benefit from a share of a £500 million investment announced ...

Twist Bioscience (NASDAQ:TWST) is scheduled to announce Q4 earnings results on Monday, November 18th, before market open. The ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...

NWD will centre on four scientific and cross-cutting themes that bring together the complementary strengths of UoM and UoL in ...